{
  "symbol": "TIL",
  "company_name": "Instil Bio Inc",
  "ir_website": "https://ir.instilbio.com/",
  "structured_data": [
    {
      "section_name": "News Articles",
      "links": [
        {
          "title": "News Releases",
          "url": "https://ir.instilbio.com/news-events/news-releases",
          "content": "[ Skip to main navigation ](#main-menu)\n\n[ ![Instil Bio logo](/sites/g/files/knoqqb75176/themes/site/nir_pid3998/dist/images/instil-bio-logo.png) ](https://instilbio.com/)\n\n  * [Home](/)\n  * [News & Events](/news-events/news-releases)\n    * [News Releases](/news-events/news-releases)\n    * [Events](/news-events/events)\n    * [Presentations](/news-events/presentations)\n  * [Stock Information](/stock-information/stock-quote-chart)\n    * [Stock Quote & Chart](/stock-information/stock-quote-chart)\n    * [Historical Price Lookup](/stock-information/historical-price-lookup)\n    * [Investment Calculator](/stock-information/investment-calculator)\n    * [Analyst Coverage](/stock-information/analyst-coverage)\n  * [Corporate Governance](/corporate-governance/governance-overview)\n    * [Documents & Charters](/corporate-governance/governance-overview)\n    * [Management Team](https://instilbio.com/about/)\n    * [Board of Directors](https://instilbio.com/about/)\n    * [Committee Composition](/corporate-governance/committee-composition)\n  * [Financials & Filings](/financial-information/sec-filings)\n    * [SEC Filings](/financial-information/sec-filings)\n  * [IR Resources](/ir-resources/investor-faqs)\n    * [FAQs](/ir-resources/investor-faqs)\n    * [Email Alerts](/ir-resources/email-alerts)\n    * [Contact IR](/ir-resources/contact-ir)\n\n\n\n# News Releases\n\nYear None2024202320222021\n\n2024\n\nNovember 13, 2024 \n\n[Instil Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update](/news-releases/news-release-details/instil-bio-reports-third-quarter-2024-financial-results-and)\n\nSeptember 16, 2024 \n\n[Instil Bio and ImmuneOnco Announce Global Registrational Strategy for PD-L1xVEGF Bispecific Antibody, SYN-2510/IMM2510, in Non-Small Cell Lung Cancer and Triple-Negative Breast Cancer](/news-releases/news-release-details/instil-bio-and-immuneonco-announce-global-registrational)\n\nAugust 13, 2024 \n\n[Instil Bio Reports Second Quarter 2024 Financial Results and Provides Corporate Update](/news-releases/news-release-details/instil-bio-reports-second-quarter-2024-financial-results-and)\n\nAugust 1, 2024 \n\n[Instil Bio and ImmuneOnco Announce License and Collaboration Agreement for Development of IMM2510, a Potentially Best-in-Class PD-L1xVEGF Bispecific Antibody, and IMM27M, a Novel Next-Generation Anti-CTLA-4 Antibody](/news-releases/news-release-details/instil-bio-and-immuneonco-announce-license-and-collaboration)\n\nMay 10, 2024 \n\n[Instil Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update](/news-releases/news-release-details/instil-bio-reports-first-quarter-2024-financial-results-and)\n\nMarch 21, 2024 \n\n[Instil Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update](/news-releases/news-release-details/instil-bio-reports-fourth-quarter-and-full-year-2023-financial)\n\nJanuary 16, 2024 \n\n[Instil Bio Announces Strategic Update](/news-releases/news-release-details/instil-bio-announces-strategic-update)\n\n[](# \"Back to top\")\n\n×\n"
        }
      ]
    },
    {
      "section_name": "Financial Reports",
      "links": [
        {
          "title": "SEC Filings",
          "url": "https://ir.instilbio.com/financial-information/sec-filings",
          "content": "[ Skip to main navigation ](#main-menu)\n\n[ ![Instil Bio logo](/sites/g/files/knoqqb75176/themes/site/nir_pid3998/dist/images/instil-bio-logo.png) ](https://instilbio.com/)\n\n  * [Home](/)\n  * [News & Events](/news-events/news-releases)\n    * [News Releases](/news-events/news-releases)\n    * [Events](/news-events/events)\n    * [Presentations](/news-events/presentations)\n  * [Stock Information](/stock-information/stock-quote-chart)\n    * [Stock Quote & Chart](/stock-information/stock-quote-chart)\n    * [Historical Price Lookup](/stock-information/historical-price-lookup)\n    * [Investment Calculator](/stock-information/investment-calculator)\n    * [Analyst Coverage](/stock-information/analyst-coverage)\n  * [Corporate Governance](/corporate-governance/governance-overview)\n    * [Documents & Charters](/corporate-governance/governance-overview)\n    * [Management Team](https://instilbio.com/about/)\n    * [Board of Directors](https://instilbio.com/about/)\n    * [Committee Composition](/corporate-governance/committee-composition)\n  * [Financials & Filings](/financial-information/sec-filings)\n    * [SEC Filings](/financial-information/sec-filings)\n  * [IR Resources](/ir-resources/investor-faqs)\n    * [FAQs](/ir-resources/investor-faqs)\n    * [Email Alerts](/ir-resources/email-alerts)\n    * [Contact IR](/ir-resources/contact-ir)\n\n\n\n# SEC Filings\n\nGroup 3,4,5Annual FilingsCurrent ReportsMergers & AcquisitionsOtherProxy FilingsQuarterly FilingsRegistration Statements\n\nFiling year - Any -202420232022202120202019\n\n- Any -\n\nItems per page 102550\n\n10\n\n[Filing date ](?items_per_page=10&order=field_nir_sec_date_filed&sort=asc \"sort by Filing date\") | [Form](?items_per_page=10&order=field_nir_sec_form&sort=asc \"sort by Form\") | [Description](?items_per_page=10&order=field_nir_sec_description&sort=asc \"sort by Description\") | Filing Group | View  \n---|---|---|---|---  \nNovember 21, 2024 | [EFFECT](/sec-filings/sec-filing/effect/9999999995-24-003547) | EFFECT |  Other |  [9999999995-24-003547.pdf](/static-files/60224ae6-8635-4703-9737-c19c4e4a7261) [9999999995-24-003547.rtf](/static-files/49ad1331-73d9-4aac-9824-d71bf0190a3a) [9999999995-24-003547.xls](/static-files/49631a9a-a982-4006-aeb3-bdc3b91ced76) [View HTML](/node/8041/html)  \nNovember 14, 2024 | [SC 13G/A](/sec-filings/sec-filing/sc-13ga/0001104659-24-119326) | An amendment to the SC 13G filing |  Other |  [0001104659-24-119326.pdf](/static-files/e19f0ba2-58b7-4d6e-9f7c-a7a5d936fe45) [0001104659-24-119326.rtf](/static-files/82411377-1c39-4262-b89e-e56ddca2f859) [0001104659-24-119326.xls](/static-files/4e2cc36c-d30f-4307-8744-fe8e0bd50dec) [View HTML](/node/8031/html)  \nNovember 14, 2024 | [SC 13G/A](/sec-filings/sec-filing/sc-13ga/0001213900-24-098624) | An amendment to the SC 13G filing |  Other |  [0001213900-24-098624.pdf](/static-files/bff4af8a-db83-41c0-8130-bf8d41360780) [0001213900-24-098624.rtf](/static-files/f0c66ea4-db6a-40b7-a96c-6ec8592371a8) [0001213900-24-098624.xls](/static-files/8a1dfc43-8956-4ccd-a76e-1517e88a5764) [View HTML](/node/8036/html)  \nNovember 13, 2024 | [8-K](/sec-filings/sec-filing/8-k/0001789769-24-000100) | Report of unscheduled material events or corporate event |  Current Reports |  [0001789769-24-000100.pdf](/static-files/ebcad32e-b3ae-4cfc-b665-bc3b9e348d07) [0001789769-24-000100.rtf](/static-files/2e320edf-2d52-4783-9111-d11d3af987e0) [0001789769-24-000100.xls](/static-files/4a3bcfa8-da69-427d-b957-8184530f8cdf) [EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA](/sec-filings/sec-filing/8-k/0001789769-24-000100) [View HTML](/node/8016/html)  \nNovember 13, 2024 | [10-Q](/sec-filings/sec-filing/10-q/0001789769-24-000103) | Quarterly report which provides a continuing view of a company's financial position |  Quarterly Filings |  [0001789769-24-000103.pdf](/static-files/046a884d-e90d-458b-9bad-2dfa9dbd8acb) [0001789769-24-000103.rtf](/static-files/57c1e2e8-48e7-446a-a53c-a50b70a2eb00) [0001789769-24-000103.xls](/static-files/e61cfd44-2bef-4b46-a042-02db8b246e51) [EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA](/sec-filings/sec-filing/10-q/0001789769-24-000103) [View HTML](/node/8021/html)  \nNovember 13, 2024 | [S-3](/sec-filings/sec-filing/s-3/0001193125-24-257343) | Simplified registration form |  Registration Statements |  [0001193125-24-257343.pdf](/static-files/50f86542-6fdc-4a44-9506-5f1a19f12704) [0001193125-24-257343.rtf](/static-files/2a7b6b40-d6d0-4811-a1a1-af48580e1d34) [0001193125-24-257343.xls](/static-files/e534f139-4595-4ecd-aaf2-5cf15aad3ed7) [View HTML](/node/8026/html)  \nOctober 25, 2024 | [SC 13G/A](/sec-filings/sec-filing/sc-13ga/0000895345-24-000481) | An amendment to the SC 13G filing |  Other |  [0000895345-24-000481.pdf](/static-files/93fa543b-7201-4754-8ca0-b0554a5c145c) [0000895345-24-000481.rtf](/static-files/672d3eaa-d605-423c-8b12-82fc74b8865a) [0000895345-24-000481.xls](/static-files/09bc5f7b-cbdf-452e-9a5d-25b9f43145b7) [View HTML](/node/7996/html)  \nOctober 22, 2024 | [SC 13D/A](/sec-filings/sec-filing/sc-13da/0001193125-24-241198) | An amendment to a SC 13D filing |  Other |  [0001193125-24-241198.pdf](/static-files/1235aed3-0645-49cc-a8a8-7cc61fb176a6) [0001193125-24-241198.rtf](/static-files/b60834b1-e338-47cc-9574-e45f52fb730c) [0001193125-24-241198.xls](/static-files/2bcee7df-83d5-467a-8aff-a3004d19c58a) [View HTML](/node/7991/html)  \nSeptember 27, 2024 | [SC 13G](/sec-filings/sec-filing/sc-13g/0001193125-24-227976) | A statement of beneficial ownership of common stock by certain persons |  Other |  [0001193125-24-227976.pdf](/static-files/3d7ec9e5-0285-4890-a534-dcef5730c19d) [0001193125-24-227976.rtf](/static-files/b7f50388-19f3-480a-aa21-a72c601b1af2) [0001193125-24-227976.xls](/static-files/90290f47-8070-4dc0-aded-5b07657ea4fe) [View HTML](/node/7981/html)  \nSeptember 27, 2024 | [SC 13G](/sec-filings/sec-filing/sc-13g/0000895345-24-000383) | A statement of beneficial ownership of common stock by certain persons |  Other |  [0000895345-24-000383.pdf](/static-files/2fbb8965-136a-4c8f-a2f0-17347dd9f3de) [0000895345-24-000383.rtf](/static-files/8dba425d-2f38-4257-904b-fcb0894e3730) [0000895345-24-000383.xls](/static-files/c3db2cfb-279b-4dc0-8b39-cf2a4e68bb16) [View HTML](/node/7986/html)  \n  \nDisplaying 1 - 10 of 191 results\n\nData provided by [Kaleidoscope](https://www.kscope.io).\n\n[](# \"Back to top\")\n\n×\n"
        }
      ]
    },
    {
      "section_name": "IR Resources",
      "links": [
        {
          "title": "FAQs",
          "url": "https://ir.instilbio.com/ir-resources/investor-faqs",
          "content": "[ Skip to main navigation ](#main-menu)\n\n[ ![Instil Bio logo](/sites/g/files/knoqqb75176/themes/site/nir_pid3998/dist/images/instil-bio-logo.png) ](https://instilbio.com/)\n\n  * [Home](/)\n  * [News & Events](/news-events/news-releases)\n    * [News Releases](/news-events/news-releases)\n    * [Events](/news-events/events)\n    * [Presentations](/news-events/presentations)\n  * [Stock Information](/stock-information/stock-quote-chart)\n    * [Stock Quote & Chart](/stock-information/stock-quote-chart)\n    * [Historical Price Lookup](/stock-information/historical-price-lookup)\n    * [Investment Calculator](/stock-information/investment-calculator)\n    * [Analyst Coverage](/stock-information/analyst-coverage)\n  * [Corporate Governance](/corporate-governance/governance-overview)\n    * [Documents & Charters](/corporate-governance/governance-overview)\n    * [Management Team](https://instilbio.com/about/)\n    * [Board of Directors](https://instilbio.com/about/)\n    * [Committee Composition](/corporate-governance/committee-composition)\n  * [Financials & Filings](/financial-information/sec-filings)\n    * [SEC Filings](/financial-information/sec-filings)\n  * [IR Resources](/ir-resources/investor-faqs)\n    * [FAQs](/ir-resources/investor-faqs)\n    * [Email Alerts](/ir-resources/email-alerts)\n    * [Contact IR](/ir-resources/contact-ir)\n\n\n\n# FAQs\n\n[Show All](#)\n\nWhere are Instil Bio's corporate headquarters located?\n\n• Instil Bio’s corporate headquarters and executive offices are in Dallas, TX.\n\nWhere is the company incorporated?\n\n• Instil Bio is incorporated in Delaware.\n\nDoes Instil Bio pay dividends?\n\n• Instil Bio does not pay a dividend and does not expect to pay one in the foreseeable future.\n\nWhat does Instil Bio’s fiscal year end?\n\n• Instil Bio’s fiscal year ends on December 31 of each year.\n\nWhat exchange does Instil Bio trade on? \n\n• Instil Bio’s shares are traded on Nasdaq.\n\nWhat is Instil Bio’s ticker symbol?\n\n• Instil Bio’s ticker symbol is “TIL”.\n\nWho makes up the Instil Bio’s Executive Management team and Board of Directors? \n\n• Members of the Instil Bio’s Executive Team and Board of Directors may be found [here](https://instilbio.com/about/).\n\nHow do I contact Instil Bio Investor Relations?\n\n• You can reach Instil Bio Investor Relations by email at investor.relations@instilbio.com\n\nHow can I get added to Instil Bio’s mailing list?\n\n• You can sign up for e-mail alerts notifying you of new press releases, SEC filings or corporate actions and events by clicking [here](https://instilbio.gcs-web.com/ir-resources/email-alerts).\n\n[](# \"Back to top\")\n\n×\n"
        }
      ]
    }
  ]
}